LCFA - Lung Cancer Foundation of America:


Follow us on			Sign up for LCFA UPDATES

Welcome to LCFA, the LUNG CANCER FOUNDATION OF AMERICA

The Lung Cancer Foundation of America's mission is to save lives by dramatically increasing the five-year survival rates for all stages of lung cancer, the nation's leading cause of cancer deaths for both men and women. The LCFA will accomplish this by providing the necessary and critical funding for creative and leading edge lung cancer research programs.

ANNOUNCEMENTS

New Targeted Therapy Treatment for Lung Cancer

Exciting new research is evolving that can test your lung cancer tumor tissue for specific gene mutations. Once your specific tumor mutation is identified, you can then be matched to a targeted therapy that is specifically linked to your unique tumor mutation.
Targeted Therapies Questions and Answers Brochure

Targeted Therapies Questions and Answers Poster

Order Your Targeted Therapies Questions and Answers Brochures

LCFA's 2011 Year - End Letter
We are grateful for all your support in 2011 and look forward to an even more successful 2012.
Click here to read the letter.

LCFA IN THE NEWS

01/05/2011 |: Lung Cancer ... Through My Eyes - Lori Monroe
01/20/2011 |: Inhaling life, Exhaling our experiences..... -Tiffiany Hora
03/05/2010 |: Guest Blog - New lung cancer treatment significantly extends lives!

LATEST IN LUNG CANCER RESEARCH

11/23/2010 |: Doctor Fights Cancer With Miracle Treatment
11/16/2010 |: Low-Dose CT Shows Clear Mortality Benefit for Lung Cancer Screening in Heavy Smokers

LCFA Donates over $250,000 in Research Grants
Because of your generous contributions, LCFA will award another $100,000 in lung cancer research grants for 2012. This is in addition to awards announced in partnership with the International Association for the Study of Lung Cancer (IASLC), in 2011 for the renewal of the LCFA Lung Cancer Research Grant for $125,00.00 to Dr. Jessica Donington at NYU for her research involving the understanding of the role of a specific protein called osteopontin in the growth and metastatic spread of non small cell lung cancer. In 2010, LCFA in partnership with IASLC, not only awarded Dr. Jessica Donington an initial $125,000, but also awarded $39,000 to
Dr. Goeffrey Liu for his study of the genetic differences in patients treated with anti-angiogenic agents to see if he can identify which patients benefit from this therapy.

Click here for more information on the LCFA Grant Award winners.